DE602005016831D1 - - Google Patents

Info

Publication number
DE602005016831D1
DE602005016831D1 DE602005016831T DE602005016831T DE602005016831D1 DE 602005016831 D1 DE602005016831 D1 DE 602005016831D1 DE 602005016831 T DE602005016831 T DE 602005016831T DE 602005016831 T DE602005016831 T DE 602005016831T DE 602005016831 D1 DE602005016831 D1 DE 602005016831D1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005016831T
Other languages
German (de)
Inventor
Yasuharu Nishimura
Tetsuya Nakatsura
Yoshiaki Ikuta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kumamoto University
Original Assignee
Kumamoto University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumamoto University filed Critical Kumamoto University
Publication of DE602005016831D1 publication Critical patent/DE602005016831D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4722—Proteoglycans, e.g. aggreccan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602005016831T 2004-10-19 2005-08-09 Expired - Lifetime DE602005016831D1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004303688 2004-10-19
PCT/JP2005/014567 WO2006043362A1 (ja) 2004-10-19 2005-08-09 悪性黒色腫(メラノーマ)の新規な診断キット

Publications (1)

Publication Number Publication Date
DE602005016831D1 true DE602005016831D1 (cg-RX-API-DMAC7.html) 2009-11-05

Family

ID=36202786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016831T Expired - Lifetime DE602005016831D1 (cg-RX-API-DMAC7.html) 2004-10-19 2005-08-09

Country Status (6)

Country Link
US (1) US8017345B2 (cg-RX-API-DMAC7.html)
EP (1) EP1813943B1 (cg-RX-API-DMAC7.html)
JP (1) JP4834839B2 (cg-RX-API-DMAC7.html)
AU (1) AU2005297303B2 (cg-RX-API-DMAC7.html)
DE (1) DE602005016831D1 (cg-RX-API-DMAC7.html)
WO (1) WO2006043362A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5299942B2 (ja) 2005-08-09 2013-09-25 オンコセラピー・サイエンス株式会社 HLA−A2陽性者用glypican−3(GPC3)由来癌拒絶抗原ペプチド及びこれを含む医薬
RU2451521C2 (ru) * 2006-06-16 2012-05-27 Онкотерапи Сайенс, Инк. Sparc-производные антигенные пептиды отторжения опухоли и лекарственные средства, содержащие их
US20110160080A1 (en) 2008-05-14 2011-06-30 Chang Sherman H Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis
NZ623273A (en) * 2008-12-05 2015-09-25 Abraxis Bioscience Llc Sparc binding scfvs
JP2013505268A (ja) * 2009-09-18 2013-02-14 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー 癌の治療におけるsparc微小環境シグネチャの使用
US9096660B2 (en) 2010-04-26 2015-08-04 Abraxis Bioscience, Llc SPARC binding antibodies and uses thereof
AU2011261240A1 (en) 2010-06-03 2013-01-10 Abraxis Bioscience, Llc Use of the SPARC microenvironment signature in the treatment of cancer
US20130281376A1 (en) * 2010-10-08 2013-10-24 Abraxis Bioscience, Llc Sparc microenvironment signature, plasma sparc, and ldh as prognostic biomarkers in the treatment of cancer
US9465030B2 (en) 2012-06-18 2016-10-11 National Cancer Center Kit for diagnosing malignant melanoma
US20140314697A1 (en) * 2013-04-18 2014-10-23 Corum Inc. Method for Inhibiting Inflammation and Reducing Melanophilin Expression with Glycine Derivatives And the Composition Thereof
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CA3134936A1 (en) 2019-03-26 2020-10-01 Dermtech, Inc. Novel gene classifiers and uses thereof in skin cancers
WO2022026381A1 (en) 2020-07-27 2022-02-03 Board Of Regents, The University Of Texas System Contrast agents for detection of enzyme activities based on melanin synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
WO2004005883A2 (en) * 2002-07-02 2004-01-15 The Johns Hopkins University Secreted and cytoplasmic tumor endothelial markers
JP5112615B2 (ja) 2002-08-30 2013-01-09 株式会社メディネット 癌抗原及びその利用
ATE511550T1 (de) * 2003-07-17 2011-06-15 Pacific Edge Biotechnology Ltd Marker zum nachweis von magenkrebs
CN1894587A (zh) 2003-10-29 2007-01-10 财团法人熊本高新技术产业财团 恶性黑色素瘤(melanoma)的诊断试剂

Also Published As

Publication number Publication date
EP1813943B1 (en) 2009-09-23
AU2005297303A1 (en) 2006-04-27
EP1813943A1 (en) 2007-08-01
US8017345B2 (en) 2011-09-13
JP4834839B2 (ja) 2011-12-14
EP1813943A4 (en) 2007-12-12
US20090111095A1 (en) 2009-04-30
AU2005297303B2 (en) 2011-11-10
WO2006043362A1 (ja) 2006-04-27
JPWO2006043362A1 (ja) 2008-05-22

Similar Documents

Publication Publication Date Title
FR17C1027I1 (cg-RX-API-DMAC7.html)
JP2005058238A5 (cg-RX-API-DMAC7.html)
JP2005284609A5 (cg-RX-API-DMAC7.html)
JP2004219423A5 (cg-RX-API-DMAC7.html)
JP2004256098A5 (cg-RX-API-DMAC7.html)
JP2005228416A5 (cg-RX-API-DMAC7.html)
JP2005128019A5 (cg-RX-API-DMAC7.html)
BE2015C034I2 (cg-RX-API-DMAC7.html)
JP2005252764A5 (cg-RX-API-DMAC7.html)
JP2005005685A5 (cg-RX-API-DMAC7.html)
JP2005040137A5 (cg-RX-API-DMAC7.html)
JP2004339201A5 (cg-RX-API-DMAC7.html)
JP2005286377A5 (cg-RX-API-DMAC7.html)
JP2005316132A5 (cg-RX-API-DMAC7.html)
ECSDI045281S (cg-RX-API-DMAC7.html)
JP2005267409A5 (cg-RX-API-DMAC7.html)
JP2005293207A5 (cg-RX-API-DMAC7.html)
JP2005251919A5 (cg-RX-API-DMAC7.html)
JP2005107517A5 (cg-RX-API-DMAC7.html)
JP2005273107A5 (cg-RX-API-DMAC7.html)
JP2005220491A5 (cg-RX-API-DMAC7.html)
JP2005199882A5 (cg-RX-API-DMAC7.html)
JP2004287415A5 (cg-RX-API-DMAC7.html)
JP2005198964A5 (cg-RX-API-DMAC7.html)
JP2005277228A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition